Long-acting adrenomedullin derivative
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- UNIVERSITY OF MIYAZAKI
- Publication Date
- 2020-01-10
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
Technical field
[0001] The present invention relates to a long-acting adrenomedullin derivative. Background technique
[0002] Adrenomedullin (also described as "AM" hereinafter) is a biologically active peptide isolated and identified from pheochromocytoma tissue in 1993 (Non-Patent Document 1). At the beginning of the discovery, it has been confirmed that AM can exert a strong antihypertensive effect of expanding blood vessels. For example, Patent Document 1 describes a peptide containing a human AM amino acid sequence that has a blood pressure lowering effect.
[0003] Subsequent studies have shown that AM can play a variety of pharmacological effects such as cardiovascular protection, anti-inflammatory effects, angiogenesis and promoting tissue repair. In addition, in order to apply the pharmacological effects of AM in the treatment of diseases, studies on the administration of AM have been conducted for patients with various diseases. Among them, AM is expected to be useful...